Predict your next investment

Other

See what CB Insights has to offer

Investments

1

About Tairui Investment

Tairui Investment (泰睿投资) is based in China.

Tairui Investment Headquarter Location

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Tairui Investment News

Qiming Venture Leads $8M Series A Round In Chinese CRO Start-Up dMed

Dec 1, 2016

Tweet Qiming Venture Capital has led a US$8 million series A funding round in dMed Co., Ltd., a Chinese clinical contract research organization (CRO), with participation from Tairui Investment and ZAI Laboratory. The company says that it will use the latest proceeds to expedite the expansion of its current team, including assurance and clinical operations professionals, according to an announcement. "Established by a group of people with profound global R&D experience, this company has the potential to become an international brand for providing drug innovation services and solutions," says Nisa Leung, Qiming’s managing partner. dMed was founded in August of 2016 by Dr. Lingshi Tan, formerly the founder and general manager of Pfizer’s Global R&D Center in China. He led the center to become a large organization with over 1,000 professionals. In a short period of time, the company has secured clients including ZAI Laboratory’s PARP inhibitor for ovarian cancer and HUA Medicine’s GKA for diabetes. Both of these companies are Qiming's portfolio companies. "China biopharmaceutical has entered into a historic turning point. Innovation has become the inevitable trend of this evolving industry. Many R&D based biopharmaceutical companies have advanced their innovative products into the clinical development stage. However, this is the stage at which they may face bottlenecks," explains Dr. Tan on his intentions of founding the company. [Please send your news, tips, and feedback to [email protected] ]

Tairui Investment Investments

1 Investments

Tairui Investment has made 1 investments. Their latest investment was in dMed Biopharmaceutical as part of their Series A on November 11, 2016.

CBI Logo

Tairui Investment Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/30/2016

Series A

dMed Biopharmaceutical

$8M

Yes

8

Date

11/30/2016

Round

Series A

Company

dMed Biopharmaceutical

Amount

$8M

New?

Yes

Co-Investors

Sources

8

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.